#Japan #Shinjuku #Vands Clinic #TISSIVO

Vands Clinic Shinjuku to Introduce TISSIVO

Vands Clinic Shinjuku, located in the heart of Shinjuku, Tokyo, is set to introduce TISSIVO, a highly anticipated skin booster from South Korea, beginning in September 2026. This innovative treatment has been making waves in the beauty industry for its unrivaled ability to rejuvenate the skin by directly supplying essential components that support the skin's structure.

What is TISSIVO?

TISSIVO stands out as a cutting-edge fifth-generation skin booster formulated with human-derived acellular dermis (hADM). Unlike traditional skin boosters that often rely on hyaluronic acid for hydration or collagen stimulation, TISSIVO utilizes biocompatible collagen and extracellular matrix (ECM) components. This approach allows for a more direct replenishment of the skin's structure, aiding in the restoration of firmness and elasticity lost due to aging, dryness, and UV damage.

Key Features of TISSIVO

• - Biocompatibility: TISSIVO's formulation employs an acellular dermal matrix that eliminates cellular components that may trigger immune responses, ensuring it integrates seamlessly with the skin for natural volume and texture enhancement.
• - ECM Environment Reconstruction: Beyond just collagen, TISSIVO forms a supportive framework that retains elastin and various growth factors, helping to maintain skin firmness and hydration from within.
• - Multi-faceted Skin Concerns: This treatment addresses a variety of skin issues, including dryness, fine lines, loss of elasticity, enlarged pores, and uneven texture, making it a versatile solution for many skin types.

Who Should Consider TISSIVO?

TISSIVO is particularly beneficial for those who:

• - Are concerned about sagging skin and loss of elasticity.
• - Have not achieved satisfactory results from traditional skin boosters.
• - Aim for a natural glow and better skin texture.
• - Wish to target specific areas such as the neck and around the eyes for hydration and fine line reduction.
• - Prefer treatments with minimal downtime for skin improvement.

Frequently Asked Questions (FAQ)

Q: What exactly is TISSIVO?
A: TISSIVO is an injectable skin booster made from human-derived acellular dermis (hADM) and ECM (extracellular matrix) that directly replenishes collagen structures in the dermal layer for firmer, glossier, and smoother skin.

Q: How does TISSIVO differ from other skin boosters?
A: Unlike traditional hydrating boosters or those that stimulate collagen production, TISSIVO is uniquely designed to directly replenish skin-supporting components derived from human sources (hADM).

Q: What is the duration of the procedure and the downtime involved?
A: The overall treatment time, including anesthesia, is about 30 to 40 minutes, with the actual injection taking around 10 to 15 minutes. While mild redness or pinpoint bleeding may occur, these effects typically settle within a few days.

Q: How much does it cost?
A: The procedure costs 77,000 yen (tax included) per session, with no public health insurance coverage available.

Q: How many sessions are recommended?
A: A series of three sessions at intervals of about 2 to 4 weeks is typically recommended, tailored to individual skin conditions and goals as determined by a physician.

Overview of Vands Clinic Shinjuku

• - Name: Vands Clinic Shinjuku
• - Address: 3-26-18 Shinjuku, 3rd and 4th Floor, Kawano Building, Shinjuku, Tokyo
• - Operating Hours: Daily from 10 AM to 7 PM, with treatments available during lunchtime.
• - Closed: Irregular holidays.
• - Phone: 03-6380-4377
• - Official LINE ID: @180ojgsb
• - Website: Vands Clinic Shinjuku
• - Booking Methods: Through Official LINE or online reservations.

Additional Information

TISSIVO is acquired through individual import under a physician's judgment. There are currently no domestic approvals for products with identical components and effects. TISSIVO is produced adhering to the standards set by the South Korean Ministry of Food and Drug Safety (MFDS).

Note on Treatments

This treatment is classified as a self-paying service, as public health insurance does not cover it. Costs are entirely out-of-pocket, and may vary based on individual cases. For specific pricing and treatment details, consultations will provide clarity.

Blood Donation Guidelines

Due to the use of human-derived acellular dermis (hADM), recipients of TISSIVO should consult the Japan Red Cross Society regarding blood donation eligibility.

Note that the introduction date and details regarding the procedure, pricing, and products may change. Individual responses to treatment, expected outcomes, risks, and side effects can vary.